Patrick Harper, MD
Pain Medicine · Lawrence, KSNPI 1245658715
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Boston Scientific at 31.2% of the total. Reporting peaked in 2020 at $2,429 and has fallen 94.6% since, to $132 in 2025.
Across 48 payments — averaging $110.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Vertos Medical, Inc.$1K
- Nevro Corp.$828
- Abbott$452
- Stryker$193
- MML US, Inc.$129
- plus $701 from 10 others
What the payments were for
- Consulting fees$80015%
- Travel & lodging$1,67332%
- Food & beverage$2,81853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $1,652 |
| Vertos Medical, Inc. | 3 | $1,336 |
| Nevro Corp. | 7 | $828 |
| Abbott | 5 | $452 |
| Stryker | 4 | $193 |
| MML US, Inc. | 1 | $129 |
| Medtronic(2 entities) | 2 | $120 |
| Saluda Medical Americas, Inc. | 2 | $118 |
| Avanos Medical | 2 | $117 |
| Vertiflex, Inc. | 1 | $113 |
| SPR Therapeutics, Inc | 3 | $109 |
| Novartis | 1 | $49 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| AbbVie | 1 | $18 |
| Si-bone, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,291 in reported general payments places this provider in the 55th percentile of 64 pain medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 62 | $667 |
| Pregabalin | 25 | $473 |
| Tizanidine Hcl | 25 | $449 |
| Duloxetine Hcl | 12 | $278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $216 |
| Cephalexin | 12 | $62 |
| Oxycodone Hcl | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lawrence
- Michael LangeLawrence$428
- Mallory MartinezLawrence$136
- Stephanie SchmidtLawrence$83
- Amanda ColganLawrence$51
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Mayank GuptaOverland Park$199K
- Brian GoentzelWichita$99K
- Brian KimOverland Park$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.